Document is current
Any future updates will be listed below
-
Authors
Hendrix, An https://orcid.org/0000-0002-1883-8309
Lippens, Lien https://orcid.org/0000-0003-3939-9576
Pinheiro, Cláudio https://orcid.org/0000-0003-1834-199X
Théry, Clotilde https://orcid.org/0000-0001-8294-6884
Martin-Jaular, Lorena https://orcid.org/0000-0002-1511-8576
Lötvall, Jan
Lässer, Cecilia https://orcid.org/0000-0003-1279-1746
Hill, Andrew F. https://orcid.org/0000-0001-5581-2354
Witwer, Kenneth W.
- License Information
-
More Information
Article History
Accepted: 12 June 2023
First Online: 27 July 2023
Competing interests
: A.H., C.T., A.F.H., and K.W.W. are inventors on patents and/or patent applications related to extracellular vesicle products. A.F.H. has consulted for Vivazome, Beagle Biotechnology and FujiFilm Cellular Dynamics in the field of EVs. C.L. and J.L. are inventors on multiple EV-associated patents for putative clinical utilization. J.L. owns equity in Codiak BioSciences Inc. and Exocure Biosciences Inc. and consults in the field of EVs through Vesiclebio AB. C.L. owns equity in Exocure Bioscience Inc. J.L. has previously consulted for Clara Biotech INC, Nanoview Biosciences INC, and is currently consulting for ExoCoBio INC. Ionis Pharmaceuticals, Yuvan Research, and AgriSciX have sponsored research in the laboratory of K.W.W. K.W.W. is or has been an advisory board member of ShiftBio, Exopharm, NovaDip and ReNeuron; K.W.W. holds stock options with NeuroDex; and consults privately as Kenneth Witwer Consulting. L.L., C.P. and L.M.-J. declare no competing interests.
